In vivo imaging of the spinal cord cholinergic system with PET

Journal of Computer Assisted Tomography

Volumn 23, Issue 1, 1999, Pages 25-33

  Gage, H Donald ^a   Gage, Jennifer C ^a   Chiari, Astrid ^a   Xu, Ze Min ^a   Mach, Robert H ^a   Efange, Simon M N ^b   Ehrenkaufer, Richard L E ^a   Eisenach, James C ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Animal studies; Contrast media; Emission computed tomography (PET); Spinal cord; Spinal cord, anatomy

Indexed keywords

COMPUTERIZED TOMOGRAPHY; NONINVASIVE MEDICAL PROCEDURES;

ANIMAL STUDIES; CONTRAST MEDIUM; EMISSION COMPUTED TOMOGRAPHY; EMISSION COMPUTED TOMOGRAPHY (PET); IN-VIVO; RHESUS MONKEY; SPECIFIC BINDING; SPINAL CORD, ANATOMY; SPINAL-CORD;

CONTRAST MEDIA;

4 FLUOROBENZYLTROZAMICOL F 18; CONTRAST MEDIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; CHOLINERGIC NERVE; CHOLINERGIC SYSTEM; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; RHESUS MONKEY; SPINAL CORD; TISSUE DISTRIBUTION;

EID: 0032970210     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004728-199901000-00007     Document Type: Article

References (55)

1. Rodriguez-Ithurralde D, Olivera S, Vincent O, Maruri A. In vivo and in vitro studies of glycine-and glutamate-evoked acetylcholinesterase release from spinal motor neurones: implications for amyotrophic lateral sclerosis/motor neurone disease pathogenesis. J Neurol Sci 1997;152(suppl 1):S54-61.
2. Yato Y, Fujimura Y, Nakamura M, Watanabe M, Yabe Y. Decreased choline acetyltransferase activity in the murine spinal cord motoneurons under chronic mechanical compression. Spinal Cord 1997;35:729-34.
3. Klimscha W, Tong C, Eisenach JC. Intrathecal alpha 2-adrenergic agonists stimulate acetylcholine and norepinephrine release from the spinal cord dorsal horn in sheep. An in vivo microdialysis study. Anesthesiology 1997;87:110-6.
4. Delfs JR, Saroff DM, Nishida Y, Friend J, Geula C. Effects of NMDA and its antagonists on ventral horn cholinergic neurons in organotypic roller tube spinal cord cultures. J Neural Transm 1997;104:31-51.
5. Xu Z, Tong C, Pan HL, Cerda SE, Eisenach JC. Intravenous morphine increases release of nitric oxide from spinal cord by an alpha-adrenergic and cholinergic mechanism. J Neurophysiol 1997;78:2072-8.
6. Vogelsberg V, Fong TG, Neff NH, Hadjiconstantinou M. Cholinergic deficits in aged rat spinal cord: restoration by GM1 ganglioside. Brain Res 1997;761:250-6.
7. Hood DD, Mallk KA, James RL, Tuttle R, Eisenach JC. Enhancement of analgesia from systemic opioid in humans by spinal cholinesterase inhibition. J Pharmacol Exp Ther 1997;282:86-92.
8. Eisenach JC, Detweiler DJ, Tong C, D'Angelo R, Hood DD. Cerebrospinal fluid norepinephrine and acetylcholine concentrations during acute pain. Anesth Analg 1996;82:621-6.
9. Bouaziz H, Tong C, Yoon Y, Hood DD, Eisenach JC. Intravenous opioids stimulate norepinephrine and acetylcholine release in spinal cord dorsal horn. Anesthesiology 1996;84:143-54.
10. Klimscha W, Tong C, Tommasi E, Eisenach JC. Intrathecal clonidine and dexmeditomidine stimulate acetylcholine release from spinal cord dorsal horn in sheep: an in vivo microdialysis study. Anesthesiology 1995;83:A793.
11. Yaksh TL, Grafe MR, Malkmus S, Rathbun ML, Eisenach JC. Studies on the safety of chronically administered intrathecal neostigmine methylsulfate in rats and dogs. Anesthesiology 1995;82: 412-27.
12. Chiang CY, Zhuo M. Evidence for the involvement of a descending cholinergic pathway in systemic morphine analgesia. Brain Res 1989;478:293-300.
13. Dirksen R, Nijhuis GM. The relevance of cholinergic transmission at the spinal level to opiate effectiveness. Eur J Pharmacol 1983; 91:215-21.
14. Eisenach JC, Gebhart GF. Intrathecal amitriptyline. Antinociceptive interactions with intravenous morphine and intrathecal clonidine, neostigmine, and carbamylcholine in rats. Anesthesiology 1995;83:1036-45.
15. Hood DD, Mallak KA, Eisenach JC, Tong C. Interaction between intrathecal neostigmine and epidural clonidine in human volunteers. Anesthesiology 1996;85:315-25.
16. Iwamoto ET, Marion L. Pharmacologic evidence that spinal muscarinic analgesia is mediated by an L-arginine/nitric oxide/cyclic GMP cascade in rats. J Pharmacol Exp Ther 1994;271:601-8.
17. Naguib M, Yaksh TL. Antinociceptive effects of spinal cholinesterase inhibition and isobolographic analysis of the interaction with mu and alpha 2 receptor systems. Anesthesiology 1994;80:1338-48.
18. Urban L, Willetts J, Murase K, Randic M. Cholinergic effects on spinal dorsal horn neurons in vitro: an intracellular study. Brain Res 1989;500:12-20.
19. Kotter R, Feizelmeier M. Species-dependence and relationship of morphological and electrophysiological properties in nigral compacta neurons. Prog Neurobiol 1998;54:619-32.
20. Schwartz PJ. Do animal models have clinical value? Am J Cardiol 1998;81:14D-20D.
21. Michie HR. The value of animal models in the development of new drugs for the treatment of the sepsis syndrome. J Antimicrob Chemother 1998;41(suppl A):47-9.
22. Deitch EA. Animal models of sepsis and shock: a review and lessons learned. Shock 1998;9:1-11.
23. O'Neill RD, Lowry JP, Mas M. Monitoring brain chemistry in vivo: voltammetric techniques, sensors, and behavioral applications. Crit Rev Neurobiol 1998;12:69-127.
24. de Lange EC, Danhof M, de Boer AG, Breimer DD. Methodological considerations of intracerebral microdialysis in pharmacokinetic studies on drug transport across the blood-brain barrier. Brain Res Brain Res Rev 1997;25:27-19.
25. McAdoo DJ, Hughes MG, Xu GY, Robak G, de Castro R Jr. Microdialysis studies of the role of chemical agents in secondary damage upon spinal cord injury. J Neurotrauma 1997;14:507-15.
26. 2+] upon spinal cord injury. Anal Biochem 1997;245:203-6.
27. Mazierre M. Cholinergic neurotransmission studied in vivo using positron emission tomography or single photon emission computerized tomography. Pharmacol Ther 1995;66:83-101.
28. 18F]FBT): molecular decomposition-reconstitution approach to vesamicol receptor radioligands for positron emission tomography. Appl Radiat Isot 1994;45:465-72.
29. 18F](+)-4-fluorobenzyltrozamicol: in vitro binding studies and positron emission tomography studies in nonhuman primates. Synapse 1997;25:368-80.
30. 125I]MIBT] reveals blunting of the striatal cholinergic response to dopamine D2 receptor blockade in the 6-hydroxydopamine (6-OHDA)-lesioned rat: possible implications for Parkinson's disease. Life Sci 1996;58:1367-74.
31. Efange SM, Langason RB, Khare AB. Age-related diminution of dopamine antagonist-stimulated vesamicol receptor binding. J Nucl Med 1996;37:1192-7.
32. Efange SM, Garland EM, Staley JK, Khare AB, Mash DC. Vesicular acetylcholine transporter density and Alzheimer's disease. Neurobiol Aging 1997;18:407-13.
33. Bylund DB, Yamamura HI. Methods for receptor binding. In: Methods in neurotransmitter receptor analysis. New York: Raven Press, 1990:1-37.
34. Tobin JR, Breslow MJ, Traystman RJ. Muscarinic cholinergic receptors in canine adrenal gland. Am J Physiol 1992;263:H1208-12.
35. Kuhar MJ, Unnerstall JR. Receptor autoradiography. In: Methods in neurotransmitter receptor analysis. New York: Raven Press, 1990:177-218.
36. Stahl WR, Malinow MR. A survey of physiological measurements in Macaca mulatta. Folia Primatol 1967;7:12-33.
37. Kobrine AI, Doyle TF, Rizzoli HV. Spinal cord blood flow as affected by changes in systemic arterial blood pressure. J Neurosurg 1976;44:12-5.
38. Woods RP, Mazziotta JC, Cherry SR. MRI-PET registration with automated algorithm. J Comput Assist Tomogr 1993;17:536-46.
39. Black KJ, Videen TO, Perlmutter JS. A metric for testing the accuracy of cross-modality image registration: validation and application. J Comput Assist Tomogr 1996;20:855-61.
40. Wang GJ, Volkow ND, Levy AV, et al. MR-PET image coregistration for quantitation of striatal dopamine D2 receptors. J Comput Assist Tomogr 1996;20:423-8.
41. Kasa P. The cholinergic systems in brain and spinal cord. Prog Neurobiol 1986;26:211-72.
42. Gillberg PG, Askmark H, Aquilonius SM. Spinal cholinergic mechanisms. Prog Brain Res 1990;84:361-70.
43. 3H]hemicholinium-3 binding sites in human brain. Brain Res 1989;505:306-10.
44. Arvidsson U, Riedl M, Elde R, Meister B. Vesicular acetycholine transporter (VAChT) protein: a novel and unique marker for cholinergic neurons in the central and peripheral nervous systems. J Comp Neurol 1997;378:454-67.
45. Schaefer MKH, Eiden LE, Weihe E. Cholinergic neurons and terminal fields revealed by immunohistochemistry for the vesicular acetylcholine transporter. I. Central nervous system. Neuroscience 1998;84:331-59.
46. Mazziotta JC, Phelps ME, Plummer D, Kuhl DE. Quantitation in positron emission computed tomography: 5. Physical-anatomical effects. J Comput Assist Tomogr 1981;5:734-43.
47. 18F-2-deoxyglucose in normal and pathological cases. J Comput Assist Tomogr 1983;7:937-45.
48. 11C-labeled morphine and pethidine after spinal administration to rhesus monkey. Acta Anaesthesiol Scand 1989;33:105-11.
49. Meltzer CC, Townsend DW, Kottapally S, Jadali F. FDG imaging of spinal cord primitive neuroectodermal tumor. J Nucl Med 1998; 39:1207-9.
50. Jayasundera MV, Thompson JF, Fulham MJ. Intramedullary spinal cord metastasis from carcinoma of the lung: detection by positron emission tomography. Eur J Cancer 1997;33:508-9.
51. Sasajima T, Mineura K, Itoh Y, et al. Spinal cord ependymoma: a positron emission tomographic study with (11C-methyl)-L-methionine. Neuroradiology 1996;38:53-5.
52. 18F]fluoro-2-deoxy-D-glucose. J Comput Assist Tomogr 1993;17:582-9.
53. Borbely K, Fulham MJ, Brooks RA, Di Chiro G. PET-fluorodeoxyglucose of cranial and spinal neuromas. J Nucl Med 1992; 33:1931-4.
54. Alavi A, Kramer E, Wegener W, Alavi J. Magnetic resonance and fluorine-18 deoxyglucose imaging in the investigation of a spinal cord tumor. J Nucl Med 1990;31:360-4.
55. Higano S, Shishido F, Nagashima M, et al. PET evaluation of spinal cord tumor using [11C]methionine. J Comput Assist Tomogr 1990;14:297-9.